Evaluation of Contact Lenses and Myopia.

NCT07566234 | Recruiting FDA Device

• 1 other identifier: CV-25-01
• Study Type: interventional
• Target: 110
• Locations: 1 country
• Sites: 1

Brief Summary

This study will evaluate the effect of dual focus contact lenses on Myopia prevention.

Conditions

Pre-myopia

Outcome Measures

Primary Outcomes (1)

• Myopia onset (cycloplegic SER ≤ -0.50D) in either or both eyes at 2 years.

  Through study completion, 2 years.

Study Arms (1)

Test Lens

EXPERIMENTAL

Device: Test Lens - Dual Focus

Interventions

Test Lens - Dual Focus DEVICE

Dual-Focus Contact Lens

Test Lens

Eligibility Criteria

• Age: 8 Years - 10 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17)

You may qualify if:

• Male and female children aged between 8-10 years inclusive.
• Cycloplegic SER from -0.25 (non-inclusive) to +0.75 D (inclusive) in both eyes.
• Astigmatism ≤ -1.00D in both eyes.
• Un-corrected visual acuity (UCVA) ≤ 0.1 LogMAR.
• As applicable (dependent on local requirements), the subject and parent/legal guardian will have read the Informed Assent/Consent, been given an explanation of the study, indicated an understanding and signed the forms.
• Along with their parent or guardian, be capable of comprehending the nature of the study, and be willing and able to adhere to the instructions set forth in this protocol.
• Along with their parent or guardian, agree to maintain the visit schedule and be able to keep all appointments as specified in the study protocol for the duration of the study.
• Agree and able to wear the assigned contact lenses successfully for a minimum of 10 hours per day, at least 6 days per week, for the duration of the study and to inform the study investigator if this schedule is interrupted. (Wearing time may be modified by the study staff for health reasons.)
• Be in good general health, based on his/her and parent's/guardian's knowledge.
• Any history of myopia control interventions with in 1 month must complete a 4-weeks of washout period.

You may not qualify if:

• History of myopia control intervention (e.g., atropine, orthokeratology, soft myopia control contact lenses, red light therapy, etc. over more than 1 month)
• Currently wears rigid gas permeable contact lenses, including orthokeratology lenses.
• Current use of systemic or ocular or medications which may affect contact lens wear, tear film production, pupil size, accommodation or refractive state.
• Ocular or systemic disease that contraindicates contact lens wear.
• Active allergic conjunctivitis.
• Any ocular, systemic or neuro-developmental conditions that could influence refractive development.
• Keratoconus or an irregular cornea.
• History of clinically significant binocular vision abnormality or strabismus.
• Any active anterior segment finding that would contraindicate contact lens wear.
• The investigator for any reason considers that it is not in the best interest of the subject to participate in the study.

Sponsors & Collaborators

• CooperVision International Limited (CVIL): lead
• Shanghai Eye Disease Prevention and Treatment Center: collaborator

Study Sites (1)

Shanghai Eye Disease Prevention and Treatment Center

Shanghai, 200030, China

RECRUITING

Study Officials

• Xiangui He, PhD

  Shanghai Eye Disease Prevention and Treatment Center

  PRINCIPAL INVESTIGATOR

• Mengjun Zhu

  Shanghai Eye Disease Prevention and Treatment Center

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Baskar Arumugam Sr. Research Lead, PhD

CONTACT

925-353-8468; barumugam@coopervision.com

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: PREVENTION
• Intervention Model: SINGLE GROUP
• Sponsor Type: INDUSTRY
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: April 29, 2026
• First Posted: May 5, 2026
• Study Start: June 6, 2026
• Primary Completion (Estimated): May 1, 2029
• Study Completion (Estimated): May 1, 2029
• Last Updated: July 16, 2026

Record last verified: 2026-05

Data Sharing

• IPD Sharing: Will not share

Locations

CN (1)